Tower Research Capital (TRC)’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Tower Research Capital (TRC)’s Portfolio GNOM Stock Details GNOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-40	Closed	-$4K	–	5509
2020 Q4	$4K	Buy	+40	New	+$3.35K	﹤0.01%	4708
2020 Q1	–	Sell	-29	Closed	-$2K	–	3363
2019 Q4	$2K	Buy	+29	New	+$1.66K	﹤0.01%	3050

Other funds holding GNOM

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

MIG

McGuire Investment Group Wakefield, Rhode Island $1.14B AUM 79.59% 1-Year Est. Return

TRUADVICE Sarasota, Florida $255M AUM 14.45% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

FTUS

Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return

Tower Research Capital (TRC)'s GNOM Position: Q1 2021 in Review

Tower Research Capital (TRC) sold out of Global X Genomics & Biotechnology ETF (GNOM) in Q1 2021, closing a stake of 40 shares — an estimated $4K sold.

Tower Research Capital (TRC) first reported a position in GNOM in Q4 2019 and held it in 2 quarters. The position peaked at $4K in Q4 2020. 39 funds tracked by Wall St. Rank hold GNOM as of Q1 2021.

Tower Research Capital (TRC) reported no remaining Global X Genomics & Biotechnology ETF position as of Q1 2021 after selling out during the quarter.
Tower Research Capital (TRC) sold 40 Global X Genomics & Biotechnology ETF shares in Q1 2021, an estimated $4K.
Tower Research Capital (TRC) first reported a position in Global X Genomics & Biotechnology ETF in Q4 2019 and held it in 2 quarters.
Tower Research Capital (TRC)'s Global X Genomics & Biotechnology ETF position peaked at $4K in Q4 2020.
39 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q1 2021.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2021, filed 17 May 2021.